Indication

Leukocyte Adhesion Defect Type I

1 clinical trial

1 product

Clinical trial

Gene Therapy for Leukocyte Adhesion Deficiency-I (LAD-I): A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of the Infusion of Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector Encoding the ITGB2 Gene

Status: Completed, Estimated PCD: 2023-09-12

Product